').insertAfter(".article-content__img");$(".article-content__img div").find('div').remove();
USFDA Issues Import Alert On Glenmark Pharma's Baddi Manufacturing Plant
Glenmark Pharmaceuticals on Wednesday said the US health regulator has put its manufacturing plant at Baddi under import alert
Topics
USFDA | Glenmark Pharmaceuticals
Glenmark Pharmaceuticals on Wednesday said the US health regulator has put its manufacturing plant at Baddi under import alert.
The drugs produced at the Baddi unit can now be detained without physical examination.
The US Food and Drug Administration inspected the facility in June 2022 and subsequently placed it under "Official Action Indicated" status.
The OAI classification implied that the USFDA may withhold approval of any pending product applications or supplements filed from such facility till the outstanding observations related to non-compliance with manufacturing norms laid down by the regulator.
"We now wish to inform you that the US FDA has placed the Baddi (India) facility under import alert 66-40," Glenmark Pharmaceuticals said in a regulatory filing.
As per the USFDA, import alert 66-40 implies detention without physical examination of drugs from firms which have not met drug GMPs.
"The US revenues from products supplied from this facility contributed to 1-2 per cent of FY22 total revenues for the company," Glenmark said.
In FY22, the company posted revenue of Rs 8,141.58 crore, as per BSE records.
Glenmark said it will engage with the agency to resolve the import alert at the earliest.
(Only the headline and picture of this report may have been reworked by the Business Standard staff; the rest of the content is auto-generated from a syndicated feed.)
Subscribe to Business Standard Premium
Exclusive Stories, Curated Newsletters, 26 years of Archives, E-paper, and more!
First Published: Wed, October 26 2022. 23:15 IST
RECENT NEWS
JPMorgan Deploys AI Chatbot To Revolutionize Research And Productivity
JPMorgan has deployed an AI-based research analyst chatbot to enhance productivity among its workforce, with approximate... Read more
Private Equity And Banks: The Complex Web Of Leverage
Private equity has emerged as a significant force in the global financial landscape, driving substantial growth and inve... Read more
Financial Watchdog Highlights Unresolved Vulnerabilities In Shadow Banking Sector
The world’s leading financial stability watchdog has issued a warning about the unresolved vulnerabilities within the ... Read more
JPMorgan And Small Caps Lead Market Rally: A Sign Of Economic Optimism
In a week marked by strong financial performance, JPMorgan Chase & Co. reported a 25% rise in profits, and US small-... Read more
Big Banks Vs. Regional Banks: The Battle For Market Share
The financial industry is a competitive landscape where big banks and regional banks vie for market share. Each type of ... Read more
The Evolution Of Philanthropic Advisory Services In Private Banks
The landscape of philanthropic advisory services provided by private banks has undergone a significant transformation. T... Read more